The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanismsKarthika Natarajan, Maria R. Baer, Jasjeet Bhullar et al.|Biochemical Pharmacology|2012Cited by 91
The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2Rupashree Sen, Maria R. Baer, Zhe‐Sheng Chen et al.|Molecular Cancer Therapeutics|2012Cited by 91
The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug InteractionsJasjeet Bhullar, Maria R. Baer, Suresh V. Ambudkar et al.|PLoS ONE|2013Cited by 32